NewEdge Advisors’s Nexalin Technology NXL Stock Holding History

NewEdge Advisors’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$19.5K	–	4105
2025 Q1	$19.5K	Buy	+10,000	New	+$27.3K	﹤0.01%	2878

Other funds holding NXL

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

NewEdge Advisors's NXL Position: Q2 2025 in Review

NewEdge Advisors sold out of Nexalin Technology (NXL) in Q2 2025, closing a stake of 10,000 shares — an estimated $19.5K sold.

NewEdge Advisors first reported a position in NXL in Q1 2025 and held it in 1 quarter. The position peaked at $19.5K in Q1 2025. 21 funds tracked by Wall St. Rank hold NXL as of Q2 2025.

NewEdge Advisors reported no remaining Nexalin Technology position as of Q2 2025 after selling out during the quarter.
NewEdge Advisors sold 10,000 Nexalin Technology shares in Q2 2025, an estimated $19.5K.
NewEdge Advisors first reported a position in Nexalin Technology in Q1 2025 and held it in 1 quarter.
NewEdge Advisors's Nexalin Technology position peaked at $19.5K in Q1 2025.
21 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.